Europe Health Technology Assessment Associate Lead

About the Role

This position involves partnering with regional access leads to identify and anticipate evidence needs from Health Technology Assessment (HTA) stakeholders across Europe. Collaborating with internal cross-functional teams is key to gathering and synthesizing evidence for EU HTA-related projects, including PICO surveys and data consolidation.

In this role, you will support the development of market access strategies and clinical development plans within the oncology portfolio, with a specific focus on evidence requirements for HTA and payer stakeholders in Europe and Canada. Co-leading the preparation and submission of HTA documents, such as Joint Clinical Assessments and Joint Scientific Consultations, will be part of your responsibilities, ensuring adherence to EU Joint HTA guidelines and processes.

Additionally, this role promotes the core values and fosters collaboration with cross-functional and global partners to enhance awareness and adherence to EU HTA evidence requirements.

Your Contributions

• Co-lead the strategy and development of high-quality HTA government submission dossiers for European Joint Clinical Assessments and Joint Scientific Consultations for new oncology medicines.
• In partnership with global and EUCAN Payer Value and Access leads, ensure timely completion of comprehensive HTA and payer evidence requirement mapping via PICO simulations for assigned assets.
• Act as a key member of the Payer Value and Patient Access sub-team, representing the joint EU HTA archetype's evidence needs in internal regional and global forums.
• Collaborate closely with the EUCAN Access Lead on Joint Scientific Consultations and Joint Clinical Assessment submission teams.
• Serve as a single point of contact for all JCA and JSC related evidence topics regarding assigned priority assets.
• Guide internal stakeholders on methodological requirements and specifications for EU HTA Regulation methods to complement existing product area expertise.
• Maintain up-to-date knowledge of EU HTA guidelines, methods, and processes, and communicate relevant updates to stakeholders.
• Provide strategic insights regarding trends and collaborations with national HTA/payers and regulatory agencies, shaping EU joint HTA and reimbursement strategies.

Qualifications and Skills

Required Qualifications:

• Minimum bachelor’s degree, with advanced/graduate degree preferred.
• A minimum of 6 years of experience in the biopharmaceutical industry or healthcare consulting.
• At least 4 years of experience in market access, health economics, pricing, health policy, or outcomes research.
• Strong understanding of the EU payer and HTA environment and methodologies.
• Demonstrated advanced verbal and written communication, presentation, and influencing skills.
• Ability to manage complex projects with multiple stakeholders effectively.
• Solid knowledge of drug development processes.
• Experience in navigating ambiguity and driving towards optimal HTA submission deliverables.
• Capacity to convert evidence into clear value messages for advocacy with stakeholders.
• Hands-on experience with HTA tools, value materials, and evidence synthesis approaches.

Preferred Qualifications:

• Advanced/graduate degree (e.g., MSc, PhD, MPH, MPP, MBA).
• Degree or certificate in health economics or economic evaluations.
• Previous experience in Oncology.
• Experience in a regional or global role.
• Direct experience leading national HTA submissions is a plus.

Travel Requirements

Approximately 20% domestic and/or international travel required.

Additional Information

Prior experience in assessing evidence needs for major HTA/payer stakeholders from EU5 and/or Canada is beneficial, along with excellent collaboration and communication skills. Experience in internal stakeholder management and a solution-oriented mindset are essential, as is a strong understanding of the clinical development process.